| 1 |
33511217 | Tofacitinib Ameliorates Lipopolysaccharide-Induced Acute Kidney Injury by Blocking the JAK-STAT1/STAT3 Signaling Pathway. | 2021 |
1 |
| 2 |
34052462 | The JAK inhibitor Tofacitinib inhibits structural damage in osteoarthritis by modulating JAK1/TNF-alpha/IL-6 signaling through Mir-149-5p. | 2021 Oct |
2 |
| 3 |
34618622 | Tofacitinib enhances remyelination and improves myelin integrity in cuprizone-induced mice. | 2021 Dec |
1 |
| 4 |
32745758 | Inhibition of colitis by ring-modified analogues of 6-acetamido-2,4,5-trimethylpyridin-3-ol. | 2020 Oct |
1 |
| 5 |
28601639 | Tofacitinib ameliorates atherosclerosis and reduces foam cell formation in apoE deficient mice. | 2017 Aug 19 |
1 |
| 6 |
28754958 | A study on the risk of fungal infection with tofacitinib (CP-690550), a novel oral agent for rheumatoid arthritis. | 2017 Jul 28 |
1 |
| 7 |
24431283 | Combination of tumor necrosis factor α and interleukin-6 induces mouse osteoclast-like cells with bone resorption activity both in vitro and in vivo. | 2014 Jan |
1 |